Skip to main content

Table 1 Allele and genotype frequencies of APO (a) (PNR), APO E, APO CI and APO CII in control and CAD groups.

From: Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease

Allele Allele frequencies Genotype Genotype Frequencies
  Control (N = 100) CAD (N = 80)   Control (N = 100) CAD (N = 80)
APO (a)      
*7 0.145 0.168 7/7 0.020 0.020
*8 0.645 0.650 7/8 0.210 0.240
*9 0.100 0.037 8/8 0.430 0.400
*10 0.045 0.087 8/9 0.110 0.040
*11 0.065 0.056 8/10 0.040 0.100
    8/11 0.070 0.120
    9/10 0.020 0.020
    Others 0.100 0.060
P 0.276   0.182
APO E      
*E2 0.045 0.037 E2/E2 - -
*E3 0.870 0.876 E2/E3 0.080 0.080
*E4 0.085 0.087 E2/E4 0.010 -
    E3/E3 0.780 0.760
    E3/E4 0.130 0.160
    E4/E4 - -
P 0.917   0.835
APO CI      
*H1 0.915 0.893 H1/H1 0.830 0.820
*H2 0.085 0.107 H1/H2 0.170 0.180
P 1   1
APO CII      
*A1 0.555 0.512 A1/A1 0.310 0.320
*A2 0.445 0.488 A1/A2 0.490 0.400
    A2/A2 0.200 0.280
P 0.618   0.635
  1. Alleles (*H1, *A1) and (*H2, *A2) indicate absence and presence, respectively, of the enzyme restriction site.
  2. P: Probability values for the comparison of allele and genotype frequencies between controls and CAD.